See If You May Qualify for an AD Study

The APG279-101 Study is evaluating a combination of study drugs for adults with atopic dermatitis.

Answer the questions below to see if you may qualify.

© 2025 Clinical Trial Media. All Rights Reserved. The images contain models and are being used for illustrative purposes only.

Privacy Policy Legal Notice